Environmental Protection Agency
Science Advisory Board

Human Health Research Strategy Review Panel

Introductory Panel Information

This document contains a summary statement prepared by each Panelist in order to
introduce them and give an overview of their background and experience.

Dr. James Klaunig (Chair): Dr. Klaunig is Professor of Toxicology and Director of
Toxicology in the Department of Pharmacology and Toxicology at Indiana University
School of Medicine. He also serves as the Director of the Department of Toxicology for
the State of Indiana. He received his BS degree from Ursinus College in Collegeville Pa.,
an MA from Montclair State University, Montclair, NJ, and his PhD from the University
of Maryland in Baltimore, MD. He is the recipient of numerous awards including fellow
of the Academy of Toxicological Sciences, the Otis R. Bowen, M.D. Distinguished
Leadership Award, Indiana University School of Medicine and the Kenneth P. DuBois
Award, and Midwest Society of Toxicology. He serves on several toxicology and
pathology editorial boards including as associate editor of Toxicological Sciences. He
has published over 150 peer-reviewed manuscripts in the field of toxicology and
carcinogenesis. Since January 2000 he has been a Member, NIH National Toxicology
Program Board of Scientific Counselors. He also has served as president of the
carcinogenesis specialty section, president of the Ohio valley Society of Toxicology chair
of the education committee, and finance committee member of the society of toxicology.
He is currently the Treasurer- elect of the Society of Toxicology. He also serves the State
of Indiana on the Indiana Pesticide review Board, the Governor's Council on Impaired
and dangerous driving and on the Indiana Controlled substances Advisory Board. He has
trained over 50 graduate students and postdoctoral fellows. His research interests are
dedicated to understanding the mechanisms of chemically induced carcinogenesis
specifically the mode of action of nongenotoxic carcinogens, role of oxidative stress in
carcinogenesis and cell injury, and understanding of the multistage nature of the cancer
process. His current research support includes the following grants: Xenobiotic
Modulation of Hepatic Gene Expression by Oxidative Stress (NIEHS,); Potential
Mechanisms for Rodent Liver Toxicity by 2-Butoxyethanol (American Chemistry
Council); Studies on the Mechanisms of 1,3-Dichloropropene Induced Rodent Hepatic
and Pulmonary Toxicity (Dow Chemical Co); Chemical Testing for Intoxication (State of
Indiana); Forensic Toxicology Instrument Upgrade for Indiana (NHTSA/State of
Indiana); Law Enforcement Drug and Alcohol Detection Training (State of Indiana).


-------
Dr. Paul Blanc: Dr. Blanc is Professor of Medicine and Endowed Chair in Occupational
and Environmental Medicine at the University of California San Francisco where he
serves as Chief of the Division of Occupational and Environmental Medicine. He has
been on the faculty at UCSF since 19888. In 1987 - 1988 he was a Fulbright Senior
Research Scholar at Ben Gurion University of the Negev, Beer Sheva, Israel and in 1985
- 1987 a Robert Wood Johnson Clinical Scholar at the University of California San
Francisco, He completed his residency in Internal and Occupational Medicine at Cook
County Hospital, Chicago. He holds an MD from Albert Einstein College of Medicine
and an MSPH in Environmental Health Sciences and Industrial Hygiene from the
Harvard School of Public Health. He received his BA from Goddard College (Plainfield,
Vermont).

Dr. Blanc is a Fellow of the American College of Chest Physicians and a member of the
Western Society for Clinical Investigation. He currently serves as a member of the Safety
and Occupational Health Study Section, NIH and of the Scientific Review Panel on
Toxic Air Contaminants, California Air Resources Board. He also serves Associate
Medical Director, California Poison Control System, San Francisco Division. He has
authored or co-authored numerous scholarly publications in the field of occupational and
environmental health.

Dr. James Gibson: Dr. Gibson is a Research Professor of Pharmacology and Toxicology
at The Brody School of Medicine at East Carolina University in Greenville, NC since
July 1, 2002 and Fellow, Academy of Toxicological Sciences. Previously, Dr. Gibson
was Global Leader, for the Health, Environmental Sciences and Regulatory Functions for
Dow AgroSciences. He was Director of Research and Development for North America
and Global Director of Regulatory, Toxicology and Environmental Affairs for
DowElanco and Director of Toxicology Affairs for the Dow Chemical Company. From
1976-1989 Gibson was Vice President and Director of Research for the Chemical
Industry Institute of Toxicology and established the scientific staff and research programs
from the inception of this independent, non-profit research institute. He started his career
in 1969 at Michigan State University where he was a professor in the Department of
Pharmacology through 1976 and a visiting professor at the Pharmakologishes Institut, der
Universitat Mainz in Mainz, Germany in 1975 and 1976. Dr. Gibson received his B.A.
from Drake University and his M.S. and Ph.D. degrees in Pharmacology from the
University of Iowa and completed the Executive Program in the Graduate School of
Business Administration at the University of North Carolina at Chapel Hill. He is a
recipient of the Alexander von Humboldt Senior U.S. Scientist Award and the Society of
Toxicology Achievement Award. He is currently an adjunct professor at Indiana
University School of Medicine, Purdue University School of Pharmacy, and North
Carolina State University Department of Toxicology. Gibson has served in various
capacities on a number of professional and government advisory panels. He has served as
a member of the board of directors for the Academy of Toxicological Sciences, president
of the Society of Toxicology, associate editor, Toxicology and Applied Pharmacology,
secretary-general of the International Union of Toxicology, president of the North
Carolina Society of Toxicology, the scientific review panel for the National Library of


-------
Medicine, member of the joint Science Advisory Board/Science Advisory Panel Review
Panel for Endocrine Disruption Screening and Testing Advisory Committee and,
currently, as a member of the Food Quality Protection Act Board, and the editorial board
for Archives of Toxicology, among others. He has authored over 100 publications.
Gibson's research interests are in developing and evaluating in vitro methods for the
safety assessment and exposure assessment of products of biotechnology. Applications
for funding are pending.

Dr. Michael Jayjock: Dr. Jayjock is a Senior Research Fellow at the Rohm and Haas
Company. He holds an M.S. and Ph.D. from Drexel University. Dr. Jayjock's areas of
expertise include: human exposure assessment (specifically modeling contaminant
emission source-strength as a function of time, transport and fate indoors); human health
risk assessment, integration of estimated dermal and inhalation exposure and dose with
estimates of health risk per unit exposure. Dr. Jayjock's research activities include:
sources/sinks and backpressure concentration model development for compounds
released indoors; and development of techniques for measuring and modeling air-to-
lungs, surface-to-skin and air-to-skin exposure. Dr. Jayjock served on the EPA Science
Advisory Board's Integrated Human Exposure Committee (IHEC), the National Research
Council, Committee on Advances in Assessing Human Exposure to Airborne Pollutants;
the National Research Council, Committee on Toxicology - Subcommittee on Risk
Assessment of Flame-Retardant Chemicals; and is a member and former Chair of the
Human Health Exposure Technical Implementation Panel of the Long Term Research
Initiative of the American Chemistry Council. He was on the Program Scientific Peer
Review Team, US Environmental Protection Agency, National Exposure Research
Laboratory (NERL), Research Triangle Park, NC. His sole support for his research is
from the Rohm and Haas Company.

Dr. George Lambert: Dr. Lambert is an Associate Professor of Pediatrics and Associate
Director of the Clinical Research Center at the UMDNJ-Robert Wood Johnson Medical
School. He holds a MD degree from the University of Illinois and has had post graduate
training in: Clinical Research in Neonatology, has been an Intern and Resident at the
Harriett Lane Home, Johns Hopkins Hospital, Baltimore, Md, He was also a
Pharmacology Fellow at Children's Hospital of Philadelphia, PA. Dr. Lambert is
certified by the American Board of Pediatrics, 1979 & 1980; Neonatal/Perinatal
Medicine, 1980 and as an Instructor, Neonatal Resuscitation, 1989

Dr. Lambert is a member of the Environmental and Occupational Health Sciences
Institute (EOHSI), UMDNJ-Robert Wood Johnson Medical School and an Adjunct
Associate Professor of Pharmacy in the College of Pharmacy of Rutgers, The State
University of New Jersey. He is also a member of the Cancer Institute of New Jersey,
and Director of the Center for Child and Reproductive Environmental Health, Director,
NIH / USEPA Center for Childhood Neurotoxicology and Exposure Assessment, and the
Director, Pediatric Clinical Research Center, UMDNJ- Robert Wood Johnson Medical
School.


-------
Dr. Lambert has served as a consulting expert to a number of professional and
governmental organizations including: the Neuropharmacology Division of FDA, the
U.S. Congress, TSCA Interagency Testing Committee, Department of Energy, Oakridge
National Laboratory, Division of Chemical Assessment, Office of Orphan Products
Development, FDA; NICHD's National Neonatal Collaborative Project. He is a
Member, Committee on Drugs, American Academy of Pediatrics, (National Committee),
a Member - Human Health Effects Committee of the Joint (U.S. and Canadian)
Commission on the Great Lakes, a consultant to the World Health Organization,
Environmental Toxicology in Children. He has served on a number of US EPA Science
Advisory Board panels including the Dioxin Reassessment Panel. Dr. Lambert is a
Fellow of the American Academy of Pediatrics

Dr. Lambert's grants include: Since 1998: New York Health Department NIEHS
Award; NIEHS/US EPA Superfund Center, Co-Investigator - Mohawk Project; NIEHS
Center of Excellence (M. Gallo, PI); NIEHS training Grant in Toxicology (K Reuhl, PI);
US EPA - Effect of in utero exposure to PCB's on Sexual Maturation' NJ DHHS / CDC -
Hypospadism and Xenoestrogen exposure in humans; NIEHS- Pharmacogenetics of
environmental chemical related toxicities (JY Hung, PI); Cancer Commission of New
Jersey - Effects of Herbal products on sex hormone synthesis and metabolism; NJ
Department of Environmental Protection - Effects of Eating Newark crabs on human
health; NIEHS / USEPA Children Center for Environmental Health and Disease
Prevention- Center for Childhood Neurotoxicology and Exposure Assessment; NCI
Program Project: Tea Cancer Chemoprevention (PI CS Yang); NIEHS - The Effects of
World Trade Center on human health (PI M. Gallo —Dr Lambert's Project: The effects of
WTC on Reproductive Outcome.)

Dr. Joseph Landolph: Dr. Landolph, Jr., is Associate Professor of Molecular
Microbiology and Immunology and Pathology and a Member of the USC/Norris
Comprehensive Cancer Center in the Keck School of Medicine, and Associate Professor
of Molecular Pharmacol-ogy and Toxicology in the School of Pharmacy, at the
University of Southern California (USC) in Los Angeles, California. Dr. Landolph
received his B. S. degree in Science, majoring in Chemistry, from Drexel University in
Philadelphia, Pennsylvania, and a com-mission as a second lieutenant in the U. S. Army
reserve from ROTC training at Drexel University. He received his Ph. D. degree in
Chemistry (Physical Chemistry) from the University of California at Berkeley under
Professor Melvin Calvin (Member of the U. S. National Academy of Sciences, Nobel
Laureate). At U. C. Berkeley, Dr. Landolph stud- ied the cytochrome P450-mediated
metabolism of the carcinogen benzo(a)pyrene (BaP) to cytotoxic and carcinogenic
metabolites and molecular mechanisms of BaP-mediated cyto- toxicity and
morphological transformation in mouse liver epithelial cells and fibroblasts. He
performed postdoctoral training in Chemical Carcinogenesis under Professor Charles
Heidelberger (Member of the U. S. National Academy of Sciences) at the USC Compre-
hensive Cancer at the School of Medicine of the University of Southern California. Dr.
Landolph is the recipient of numerous awards, including an undergraduate National


-------
Sciences Foundation Research Traineeship, the Superior Cadet Award (U. S. Army
ROTC), the Merck Award in Chemistry, an American Cancer Society postdoctoral
fellowship, the ICI Traveling Lectureship Award, and the Cleland Award for Excellence
in Teaching from the Dept. of Pathology at USC. Dr. Landolph has served as a member
of the Editorial Boards of Cancer Biochemistry Biophysics and Environmental and
Molecular Mutagenesis, and frequently reviews scientific manuscripts for
Carcinogenesis, Molecular Carcinogenesis, Environmental Health Perspectives, Cancer
Research, and Chemical Research in Toxicolo- gy. He has published thirty-two peer
reviewed manuscripts and fifteen review articles/-book chapters on chemical
carcinogenesis, genetic toxicology, and molecular oncology. He has served as a
counselor of the Carcinogenesis Specialty Section of the American Society of
Toxicology, and as Vice President Elect, Vice President, and President-Elect of the
Metals Specialty Secton of the American Society of Toxicology. He is currently Presi-
dent of the Metals Specialty Section of the American Society of Toxicology. Dr.
Landolph has served for the last eight years and currently serves as a member of the
Carcinogen Iden- tification Committee of the Scientific Advisory Board of the Office of
Environmental Health Hazard Assessment of the State of California, as appointed by two
successive Governors of California. He has also served as an ad hoc member of the
Chemical Pathology Study Section and the A1TX4 Study Section of the NIH, as a
member of the Health Effects Re-view Paenl of the U. S. EPA, as a reviewer of special
RFAs for the NIEHS, as a reviewer of Center Grants for the NIEHS and EPA, and as a
reviewer of Ph. D. fellowships for the NIH and for the Howard Hughes Fellowship
Program of the National Research Council. He has also served as an external adviser for
the Center for Clean Technology and the Cli-nical Nutrition Unit at the University of
California at Los Angeles. He has trained nine Ph. D. students and thirty postdoctoral
fellows. His research interests are in understanding the molecular biology of chemical
carcinogenesis and human cancer. His laboratory specific-ally studies the molecular
mechanisms, cell biology, and molecular biology of morphologi- cal and neoplastic
transformation induced in cultured cells by insoluble nickel compounds, hexavalent
chromium compounds, polycyclic aromatic hydrocarbons, and arsenic com-pounds. His
current research support includes the following grant: Evaluation of the Rel-ative
Genotoxic Potentials of Four Nickel Samples by Short-Term Assays in C3H/10T1/2
Mouse Embryo Cells. His prior research support was from the NCI, the NIEHS, the EPA,
the Tobacco Related Disease Research Program of the State of California, and the Nickel
Producers Environmental Research Association. His current funding source is the Nickel
Producers Environmental Research Association. Dr. Landolph is also a private, part-
time consultant in Chemical Toxicology, Chemical Carcinogenesis, and Human Cancer.

Dr. Steve Lewis: Dr. Lewis holds a B.A. in Chemistry from Indiana University at
Indianapolis (1970) and a Ph.D. in Toxicology (minor in Biomedical Sciences) from
Indiana University School of Medicine (1975). Dr. Lewis joined Exxon Corporation in
1975 and has held various technical, consulting and management positions, including
Manager of the Petroleum and Synthetic Fuels Group. His research and safety
assessment activities have focused on the assessment of potential health risks from
exposure to chemical carcinogens, toxicants to the nervous system, and chemical hazards


-------
to reproductive health. As a Distinguished Scientific Associate, Dr. Lewis acts as a
corporate advisor on scientific and science-policy issues in the areas of occupational and
environmental health. Dr. Lewis received Exxon Biomedical Sciences' Exceptional
Achievement Award in 1993 and consecutive ExxonMobil Ambassador Awards in 2001
and 2002. Dr. Lewis has been a Diplomate of the American Board of Toxicology since
the Board's inception in 1980 (recertified in 1985, 1990, 1995 and 2000). He has served
on the editorial boards of 5 scientific journals (4 are current) and was recently appointed
Associate Editor for a new journal, Nonlinearity in Biology, Toxicology and Medicine.
Dr. Lewis is active in a variety of professional societies, including the Society for Risk
Analysis (elected to SRA's governing Council in 2000), the International Society for
Regulatory Toxicology and Pharmacology, and the Society of Toxicology. Dr. Lewis has
served as a Consultant to the U.S. EPA Science Advisory Board, and is a Member of the
Risk Communication Subcommittee of the EPA Board of Scientific Counselors (of the
Office of Research and Development). He is a frequent commentator on scientific and
regulatory issues before U.S., state and international agencies. He is a Past-Chair of the
American Petroleum Institute's Toxicology Committee, and a former member of the
Board of Directors of the Toxicology Forum. Dr. Lewis has served as Chair of the
American Industrial Health Council's Science Policy Committee. He currently serves as
Chair for a chemical-industry-wide research cooperative to improve risk assessment
methods for the American Chemistry Council (formerly, the Chemical Manufacturers
Association). Dr. Lewis was recently re-appointed for a second 3-year term on the Board
of Trustees of TERA/ITER (a not-for-profit organization specializing in the assessment
of health and environmental risks). Dr. Lewis also holds the title of Senior Fellow at the
Cecil and Ida Green Center for the Study of Science and Society (University of Texas at
Dallas), where he was a visiting scholar in 1995. Dr. Lewis is a nominee to the position
of Adjunct Professor of Environmental and Community Medicine at the University of
Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School. Dr.
Lewis has published and presented the results of his work widely, and has delivered
numerous invited seminars and other presentations.

Randy Maddalena: Randy Maddalena, Ph.D., is a Scientist with the Environmental
Energy Technologies Division at Lawrence Berkeley National Laboratory. The general
focus of his research is the development, evaluation and application of models that
predict chemical fate in multiple environmental media (air, water, soil, vegetation,
sediment) and analysis of chemical exposures through multiple pathways (drinking water,
food, feed, indoor air) for both human and ecological receptors. He received his
bachelor's degree in Environmental Toxicology (1992) and his Ph.D. in Agricultural and
Environmental Chemistry (1998) from the University of California, Davis. He is Co-chair
of the Society of Environmental Toxicology and Chemistry (SETAC) Advisory Group on
Fate and Exposure Modeling and has served as Editor of the Fate and Exposure Modeling
column in the SETAC Globe. His most recent work combines the use of models and
experimental data to investigate the role of plants in the environmental fate and transport
of semivolatile organic pollutants and how the uptake of these pollutants into ecological
or agricultural food chains might contribute to dietary exposures. Another area of his
research includes probabilistic exposure and risk assessment where he develops methods
for constructing exposure factor distributions and recently proposed a framework for


-------
regulators to use when reviewing PRAs. His current research support includes the
following: A Multi-Domain Framework for Integrating Models and Measurements of
Multimedia Environmental Contaminants (U.S. EPA, National Exposure Research
Laboratory); Improving Science-Based Methods for Assessing Risks Attributable to
Petroleum Residues Transferred from Soil to Vegetation (U.S. DOE, Fossil Energy
Research); Integrated Transport and Human Health and Ecological Risk Assessments For
Multimedia Pollutants (U.S. EPA, Office of Air Quality Planning and Standards); Criteria
for Evaluation and Development of Probability Density Functions for a Set of Human
Exposure Factors (U.S. EPA, Office of Emergency and Remedial Response).

Maria Morandi: Dr. Maria T. Morandi is an Assistant Professor of Environmental
Sciences and Occupational Health at the School of Public Health of the University of
Texas - Houston Health Science Center. She served as member of the Integrated Human
Exposure Assessment Committee (formerly the Indoor Air and Total Human Exposure
Assessment Committee) of the EPA Science Advisory Board during 1992 and 1998, and
has served as a member of the Research Strategies Advisory Committee since 1998. Dr.
Morandi has also served as member or chair of several EPA program review panels, the
Agency for Toxic Substances Board of Scientific Councilors, and the National Institute
of Occupational Health Study Section. .

Dr. Morandi's areas of research interest include development of sampling and analytical
methods for indoor, outdoor and personal monitoring of air pollutants in community and
work environments, exposure assessment, exposure modeling, and health effects from
exposure to airborne contaminants and related cellular and molecular mechanisms of
action. She is also certified in the practice of industrial hygiene by the American Board of
Industrial Hygiene. Dr. Morandi received a BS degree in Chemistry form the City
College of New York in 1978. She received M.S. and Ph.D. degrees in Environmental
Health from the Norton Nelson Institute of Environmental Medicine of New York
University Medical Center in 1982 and 1985.

Beate Ritz: Dr. Ritz is an Associate Professor in the Department of Epidemiology and
Center for Occupational and Environmental Health (COEH) at the School of Public
Health in the University of California, Los Angeles. She received her first Masters and
Doctorate degrees in Medicine and Medical-sociology at the University of Hamburg,
Germany. Her later MPH and Ph.D. in the field of Epidemiology were received from the
University of California, Los Angeles. Over the last seven years, Dr. Ritz has dedicated
her time and experience to train graduate and postdoctoral students. She has published
numerous peer-reviewed reports and articles discussing a wide variety of environmental
and occupational health related issues from the effects of radiation and chemical
exposures on cancer mortality in nuclear workers to the effects of ambient air pollution
on fetal development. Other publications and NIH funded research projects reflect Dr.
Ritz's interest in studying suspected environmental risk factors for Parkinson's disease.
Her ongoing research include the topics of Parkinson's disease susceptibility genes and
pesticide exposures; the evaluation and validation of pesticide use reporting in California;


-------
the evaluation of the impact of radiation and some known animal carcinogens on cancer
mortality and morbidity in nuclear workers; the effects of traffic-related air pollution and
adverse birth outcomes; and most recently a survey to identify and reduce
musculoskeletal work hazards in garment workers. Her current research support and
funding sources include the following: NIEHS; NINDS; NIOSH; CDC and ATSDR;
California Cancer Research Program; UC Toxic Substances Research & Teaching
Program; UCLA Institute of Labor And Employment; the Alzheimer's Association and
the American Parkinson's Disease Association.

Herbert Rosenkrantz: Dr. Rosenkranz is a Professor of Environmental and
Occupational Health and of Pharmacology at the University of Pittsburgh and a Research
Professor of Biomedical Sciences at Florida Atlantic University. Until recently he was
also Chair of the Department of Environment and Occupational Health and Interim Dean
of the Graduate School of Public Health at the University of Pittsburgh. Previously he
held professorships and departmental chairmanships at the College of Physicians and
Surgeons of Columbia University, New York Medical College and the School of
Medicine of Case Western-Reserve University. He has published over 570 papers in the
areas of molecular biology, toxicology, carcinogenesis, and public health. He has served
on national (NIH, EPA) and international (WHO, IARC, EU) panels and editorial boards.
He is currently funded by NIH and DoD.

Robert Spengler: Dr. Spengler is the Associate Administrator for Science at the Agency
for Toxic Substances and Disease Registry (ATSDR) in Atlanta, Georgia. He received his
BS degree from George Washington University in Washington, D.C., and his ScD from
the Johns Hopkins University School of Hygiene and Public Health in Baltimore,
Maryland. His career as an epidemiologist has included faculty positions at McGill
University, University of Toronto, University of Vermont, Southern Illinois University
and University of Chicago. He has held senior epidemiologist positions at the Ontario
Cancer Treatment and Research Foundation, Illinois Department of Public Health and
Vermont Department of Public Health. Since 1991, he has worked at ATSDR as the
Assistant Director for Science, Division of Health Studies and in 1998 began his current
position as senior scientist at ATSDR. His research interests are dedicated to the field of
environmental epidemiology and include methodology, surveillance, cancer, birth
defects, exposure assessment, and exposure-outcome relationships. He oversees the
agency's portfolio of intramural and extramural research and developed the ATSDR
Agenda for Public Health Environmental Research 2002-2010. The six focus areas of
ATSDR's applied human research program include exposure assessment, chemical
mixtures, susceptible populations, community and tribal initiatives, evaluation and
surveillance of health effects, and health promotion and intervention. He is the Executive
Secretary for the ATSDR Board of Scientific Counselors and serves on numerous
committees and working groups affiliated with CDC, EPA and NIEHS. He manages an
office under the Assistant Administrator which monitors and maintains high quality
science and research conducted or supported by ATSDR


-------
Bernard Weiss: Dr. Weiss is Professor of Environmental Medicine and Pediatrics at the
University of Rochester School of Medicine and Dentistry, where he has been a member
of the faculty since 1965. He received his BA degree from New York University and his
PhD from the University of Rochester. Before joining the faculty at Rochester, he served
on the faculty of the Johns Hopkins School of Medicine, and, earlier, held an
appointment at the U.S. Air Force School of Aviation Medicine. Dr. Weiss has served as
a member of many committees and panels devoted to toxicology and environmental
health, including those organized by the U.S. Environmental Protection Agency's Science
Advisory Board (such as the Dioxin Reassessment Review Panel and the Subcommittee
on Human Testing of Pesticides), and the National Academy of Sciences (for example,
the recent Committee on Air Quality in Passenger Aircraft). He is especially concerned
with risk assessment issues arising from the effects of environmental chemicals on brain
development and brain aging. He is the editor or co-editor of seven books and
monographs and author or co-author of over 200 articles. Dr. Weiss 's special interests
and publications lie primarily in areas that involve chemical influences on behavior; these
include the neurobehavioral toxicology of metals such as lead, mercury and manganese;
endocrine disruptors such as dioxin; solvents such as toluene and methanol; drugs such as
cocaine; and air pollutants such as ozone. In 1986 he was named

Scientist of the Year by the Learning Disabilities Association of America, and, in 1990,
was awarded the Stokinger Prize by the American Conference of Governmental
Industrial Hygienists (ACGIH). Dr. Weiss has served as president of several
organizations in the area of neurotoxicology and also serves as a member of several
public advisory groups. He also lectures frequently to lay audiences. His current and
recent grant support have been provided by NIH (specifically, the National Institute of
Environmental Health Sciences) and ATSDR (Agency for Toxic Substances and Disease
Registry).


-------